Scholarlink

Purpose of Review <p>Financial toxicity from cancer treatment is a significant barrier to equitable care and an important clinical and public health concern. This scoping review examines global patterns in the assessment of financial toxicity in cancer care and compiles an inventory of domains and subdomains used in existing assessment tools.</p> Recent Findings <p>From 3,343 records screened, 454 studies were included. Most were conducted in high-income countries (81.7%, <i>n</i> = 371), with 93.8% focused on adult populations. Across 438 quantitative studies, 164 distinct financial toxicity questionnaires comprising 1,104 questions were identified. The COmprehensive Score for financial Toxicity (COST) was the most frequently used tool (40.4%). Only 48.2% of questionnaires had undergone validation in cancer populations. The majority of questions addressed material domains (51.3%), followed by behavioral (29.9%) and psychosocial (18.8%) aspects. The most common subdomains identified were health expenditure within the material domain (9.6%), delaying or forgoing healthcare services within the behavioral domain (12.6%), and perceived financial burden of healthcare costs within the psychosocial domain (12.8%). Findings from 32 qualitative studies aligned with these patterns, highlighting healthcare costs and employment loss as key concerns.</p> Summary <p>Most studies of financial toxicity in cancer care are conducted among adults in high-income countries and measure material domains. Greater attention is needed to expand financial toxicity research in low- and middle-income countries and among pediatric, adolescent, and caregiver populations.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Mapping Disparities in the Measurement of Financial Toxicity in Cancer Care: A Scoping Review

  • 期刊论文

  • 发表日期：

    2025年11月1日

查看全文
  • Manraj Singh Sra,
  • Parth Sharma,
  • Varun Raj Passi,
  • Larry Prokop,
  • Akshithanand Kuzhikkat Jayaprakasan,
  • Disha Agrawal,
  • Jashanjot Singh Mangat,
  • Anuja Jani,
  • Japmehr Kaur Sandhu,
  • Charmaine Blanchard,
  • Enrique Soto-Perez-de-Celis,
  • Pragati B. Hebbar,
  • Arun Ghoshal

摘要

Purpose of Review

Financial toxicity from cancer treatment is a significant barrier to equitable care and an important clinical and public health concern. This scoping review examines global patterns in the assessment of financial toxicity in cancer care and compiles an inventory of domains and subdomains used in existing assessment tools.

Recent Findings

From 3,343 records screened, 454 studies were included. Most were conducted in high-income countries (81.7%, n = 371), with 93.8% focused on adult populations. Across 438 quantitative studies, 164 distinct financial toxicity questionnaires comprising 1,104 questions were identified. The COmprehensive Score for financial Toxicity (COST) was the most frequently used tool (40.4%). Only 48.2% of questionnaires had undergone validation in cancer populations. The majority of questions addressed material domains (51.3%), followed by behavioral (29.9%) and psychosocial (18.8%) aspects. The most common subdomains identified were health expenditure within the material domain (9.6%), delaying or forgoing healthcare services within the behavioral domain (12.6%), and perceived financial burden of healthcare costs within the psychosocial domain (12.8%). Findings from 32 qualitative studies aligned with these patterns, highlighting healthcare costs and employment loss as key concerns.

Summary

Most studies of financial toxicity in cancer care are conducted among adults in high-income countries and measure material domains. Greater attention is needed to expand financial toxicity research in low- and middle-income countries and among pediatric, adolescent, and caregiver populations.